SXTC: Kapitalisasi marang pendapatan SXT Pharmaceuticals

Logo korporat perusahaan SXT China (SXTC)

China SXT Pharmaceuticals (SXTC) maintains a closed-loop production cycle for Chinese medicine, controlling the entire pipeline from fields to pharmacies. This P/S chart for the company on GURU.Markets illustrates the market valuation, where the value of 0.30 expresses the metric level. Flexible raw material outsourcing through cooperatives minimizes risks, while moderate pricing power within the generics niche curbs excessive markup growth.

SXTC: Multiplikator P/S SXT China 04.07.2022 - 15.11.2026

Rincian analitis perusahaan sxtchina.com (SXTC)

- rega saham lan konsensus proyeksi valuasi:
Bagan owah-owahan rega China SXT Pharmaceuticals, Inc.|SXTC - Prakiraan konsensus analis
- informasi kapitalisasi pasar:
Biji pasar SXTC|SXTC - Nilai Perusahaan
- indikator nilai buku ekuitas:
Nilai Akuntansi Saham China SXT Pharmaceuticals|SXTC - Kapitalisasi Buku|Kapitalisasi Pasar marang Nilai Buku sxtchina.com|SXTC - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Rasio Utang marang Ekuitas China SXT Pharmaceuticals|SXTC - Utang jangka dawa marang modal|Utang jangka cendhak marang modal SXT China|SXTC - Gunggung utang perusahaan|Rasio utang marang aset resik China SXT Pharmaceuticals|SXTC - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak China SXT Pharmaceuticals|Rasio likuiditas darurat sxtchina.com
- informasi bathi lan kelipatan valuasi:
SXTC - Penghasilan resik|Bathi resik mangsa ngarep China SXT Pharmaceuticals|SXTC - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi SXT Pharmaceuticals|SXTC - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan SXTC|SXTC - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku China SXT Pharmaceuticals|SXTC - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan sxtchina.com|SXTC - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep China SXT Pharmaceuticals
- rincian pendapatan lan dodolan emiten:
SXTC - Pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan China SXT Pharmaceuticals, Inc.|SXTC - Multiplikator P/S|Multiplikator Forward P/S SXTC|SXTC - Wutah dodolan YoY (TTM)
Ringkesan analitik perusahaan:China SXT Pharmaceuticals, SXTC
Produk sing diprodhuksi China SXT Pharmaceuticals

Investors are assessing the resilience of China SXT Pharmaceuticals (SXTC) through the ratio of the business's market value to its annual turnover. This price-to-sales metric measures how many dollars of capitalization are attributed to each unit of revenue, allowing for a determination of the premium paid for the stable sales of traditional herbal medicines. Analysis of this chart helps determine whether the current undervaluation of shares is a result of market risk or a hidden entry opportunity.

Pesaing China SXT Pharmaceuticals

HLN (Haleon) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Kenvue Inc KVUE|Verona Pharma Corp - Rasio rega marang pendapatan|MENS: Kapitalisasi marang pendapatan|Koefisien rega marang pendapatan Ligand Pharmaceuticals LGND|Amneal Pharmaceuticals Inc (AMRX) - Rasio rega marang pendapatan|Perrigo Company PLC - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan alvotech.com|Multiplikator P/S Liquidia Technologies|Rasio rega marang pendapatan Galapagos Genomics (GLPG)|ANIP: Rasio rega marang dodolan|Multiplikator P/S MNKD (MannKind Corp)|Koefisien rega marang pendapatan Amphastar (AMPH)|PCRX: Kapitalisasi marang pendapatan|SPRY - Multiplikator P/S|Theravance Biopharma, Inc. (TBPH) - Rasio rega marang pendapatan|AQST (Aquestive Therapeutics) - Rasio rega marang pendapatan|SCPH (scpharmaceuticals.com) - Multiplikator P/S|TECX: Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Tonix Pharmaceuticals Inc. (TNXP)|EPRX: Rasio rega marang dodolan|BioHarvest Sciences - Kapitalisasi marang pendapatan|EXOZ: Rasio kapitalisasi marang pendapatan|ORMP - Rasio rega marang pendapatan|ENTX: Rasio rega marang pendapatan|HYFT: Multiplikator P/S|Kapitalisasi marang pendapatan ABVC BioPharma Inc|CPIX (Cumberland Corp) - Multiplikator P/S|Multiplikator P/S quantumbiopharma.com|Multiplikator P/S FGEN|Kapitalisasi marang pendapatan Telomir Pharmaceuticals, Inc. TELO|Multiplikator P/S RANI (Rani Therapeutics)|SNYR (Synergy CHC Corp) - Rasio rega marang dodolan|RLYB: Kapitalisasi marang pendapatan|lexariabioscience.com (LEXX) - Kapitalisasi marang pendapatan|Pulmatrix Inc (PULM) - Rasio rega marang pendapatan|PTHL: Kapitalisasi marang volume dodolan|APM (Aptorum Group Ltd) - Multiplikator P/S|Lyra Therapeutics Inc (LYRA) - Koefisien rega marang pendapatan|Multiplikator P/S IBO|Kapitalisasi marang volume dodolan TNFA|cbdMD, Inc. - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan PRFX|Altamira Therapeutics Ltd. - Multiplikator P/S|LIPO: Rasio rega marang pendapatan|OPTN: Multiplikator P/S|Rasio rega marang dodolan PIRS (Pieris Pharmaceuticals)|PROC (Procaps) - Multiplikator P/S|PTPI (Petros Pharmaceuticals Inc) - Kapitalisasi marang volume dodolan|Multiplikator P/S QLI|SLRN - Rega marang dodolan|Multiplikator P/S TFFP (TFF Pharmaceuticals, Inc)